| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |